Find clinical trials for Non-Hodgkin Lymphoma in Columbus, OH
CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
Related conditions:
Non-Hodgkin Lymphoma trials near Columbus, OH, USA:
to Standard Of Care in adult patients with aggressive B-cell Non-Hodgkin Lymphoma after failure of rituximab and anthracyc...
Phase 3
Columbus, Ohio, United States and 66 other locations
Part 1: To characterize the safety profile of acalabrutinib alone or in combination with rituximab in subjects with R/R FL.Part 2: To characterize th...
Phase 1, Phase 2
Columbus, Ohio, United States and 31 other locations
in participants with relapsed or refractory (R/R) CD30-expressing lymphomas.GEN3017 will be administered via subcutaneous injections.All par...
Phase 1, Phase 2
Columbus, Ohio, United States and 5 other locations
CB010A is a study evaluating safety, emerging efficacy, pharmacokinetics and immunogenicity of CB-010 in adults with relapsed/refractory B cell non...
Phase 1
Columbus, Ohio, United States and 33 other locations
who have received chimeric antigen receptor (CAR) T cell therapy for non-Hodgkins lymphoma and in whom have had a sub-opti...
Phase 1
Columbus, Ohio, United States
given together with obinutuzumab in treating patients with B-cell non-Hodgkin lymphoma that has returned after a period of...
Phase 1
Columbus, Ohio, United States and 1 other location
clinical trial will enroll patients with relapsed/refractory non-Hodgkin lymphoma of B-cell origin and is conducted in two...
Phase 1, Phase 2
Columbus, Ohio, United States and 20 other locations
This phase II trial studies how well nivolumab works with the DA-REPOCH chemotherapy regimen in treating patients with aggressive B-cell non-...
Phase 2
Columbus, Ohio, United States
bispecific antibody, in subjects with relapsed or refractory B-cell non-Hodgkin lymphoma (B-NHL) who have received 2 or mo...
Phase 1
Columbus, Ohio, United States and 28 other locations
and ibrutinib in treating patients with aggressive B-cell non-Hodgkin lymphoma that has come back (relapsed) or responded ...
Phase 1, Phase 2
Columbus, Ohio, United States and 1 other location
Clinical trials
Research sites
Resources
Legal